酸櫻桃 Tart Cherry × 痛風

結論:證據分歧

The evidence for tart cherry in gout is genuinely conflicting and small.

C 🟠 C 薄弱證據 證據分歧 ⚠️ medium — moderate promotional content
⚠️ 標記 🇹🇼 台灣在地警示

The evidence for tart cherry in gout is genuinely conflicting and small. The strongest positive signal, the Zhang 2012 case-crossover study (n=633), is observational with self-reported intake and no serum urate data, and L2 rates its quality as low; it can show association but not causation. The best-designed test, a 2020 dose-ranging RCT (n=50, moderate quality), found NO effect on serum urate, urinary urate excretion, or flare frequency at any dose, and a 2023 RCT (n=282) showed tart cherry citrate did not outperform comparators on urate. Examine graded both gout outcomes D (No effect), and the ACR 2020 guideline explicitly declined to make any recommendation, citing low-to-very-low certainty. I grade this C rather than D because a credible observational signal and a plausible anti-inflammatory mechanism exist, but rather than B/A because controlled trials do not confirm a urate-lowering or flare-reducing benefit and the evidence base is heterogeneous and unconfirmed.

⚖️

評分透明度

所有分數由 7 層證據引擎計算,過程公開可查
原始分數 0.51
D
C
B
A
S
← 反證據 / 無效有效 / 強證據 →
最終評級
C · 證據分歧
信心度
68%
證據方向大致一致
證據層級
E3
單篇高品質統合分析

各層「支持此療效」的程度

分數越低=該層越不支持
L2 PubMed原始文獻
0.45
L3 機轉生理合理性
0.45
L1 Examine國際基準
0.50
L11 AI 複核獨立判讀
0.50
L5 臨床機構權威立場
0.65
不支持 中性 / 混合 支持
查看完整決策路徑(audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.51
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 高品質 SR/MA 顯示 positive (1 篇 > 0 negative)
  4. tier_strict_requirement_check — Tier 條件達標,未降階
  5. detect_disputes — 偵測到 2 個 hard + 0 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

Cherry consumption and decreased risk of recurrent gout attacks
PMID: 23023818 2012 Observational n = 633
結論:Cherry intake over a 2-day period was associated with a 35% lower risk of gout attacks (OR 0.65, 95% CI 0.50-0.85); cherry extract alone OR 0.55; benefit plateaued at ~3 servings; combining cherry intake with allopurinol gave a 75% lower risk (OR 0.25, 95% CI 0.15-0.42). Serum uric acid data were unavailable.
🟠 品質有限 政府資助 效應量:OR 0.65 (fresh cherries); OR 0.55 (extract); OR 0.25 (cherry + allopurinol)
前往 PubMed
Lack of effect of tart cherry concentrate dose on serum urate in people with gout
PMID: 31891407 2020 隨機對照試驗 n = 50
結論:Cherry concentrate dose had no significant effect on reduction in serum urate AUC (p=0.76), urine urate excretion, or frequency of gout flares over the 28-day period.
政府資助 效應量:No significant effect at any dose
前往 PubMed
Efficacy and safety of tart cherry supplementary citrate mixture on gout patients: a prospective, randomized, controlled study
PMID: 37679816 2023 RCT (open-label) n = 282
結論:Urine pH and serum urate declined similarly across all three groups with no between-group difference. The TaCCi and citrate-mixture groups had fewer gout flares than the sodium bicarbonate group (p<0.05); the TaCCi group showed greater improvement in urinary albumin/creatinine ratio and C-reactive protein (p<0.01).
效應量:No serum urate difference vs comparators; fewer flares vs bicarbonate (p<0.05)
前往 PubMed
Effectiveness of Cherries in Reducing Uric Acid and Gout: A Systematic Review
PMID: 31885677 2019 系統性回顧 n = 941
結論:Across 6 heterogeneous studies (~941 participants) current evidence supports an association between cherry intake and reduced gout attack risk; one study reported a 35% reduction in recurrent attacks and another a 19.2% reduction in serum uric acid. Heterogeneity precluded meta-analysis.
🟠 品質有限 效應量:Association only; up to 35% lower attack risk, ~19% lower serum uric acid in individual studies
前往 PubMed

L4a US FDA
謹慎
articles intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease in man... are drugs 來源↗
L4b EU EFSA
反對
L4c UK NHS
未表態
— 本適應症無對應資料
L4d TW TFDA / 衛福部
中性
L4e WHO
未表態
— 本適應症無對應資料

L5a NIH Office of Dietary Supplements
謹慎
L5b Mayo Clinic
謹慎
Some studies show that eating cherries may lower the risk of gout attacks. 來源↗
L5c Cleveland Clinic
支持
L5d Harvard Health
謹慎
L5e Specialty Society (condition-mapped)
支持

PTT · Dcard · Mobile01 彙整自公開論壇討論,非統計抽樣,僅反映社群風向。
廣告 / 業配密度 中度
📍立場總覽

PTT 跑步/健康/購物板有討論酸櫻桃用於痛風與運動恢復,但經驗分歧:助眠/恢復多人有感,降尿酸防痛風則少有實測回饋,痛風族群多半改推赤晶對策等專利配方。多數人視酸櫻桃為輔助、安慰劑成分偏高,並提醒急性發作仍要吃藥。

💬社群實感

分歧(助眠/運動恢復偏正面,痛風降尿酸無共識、實測回饋少)

破解迷思 社群最常見的 4 個誤解
事實「吃櫻桃/酸櫻桃可以降尿酸」被當成定論,但社群實測多無感,產品本身也常未標示降尿酸功效
事實把酸櫻桃膠囊當成痛風主要療法,忽略其僅為輔助、急性發作仍須吃藥
事實將酸櫻桃與西印度櫻桃(嘌散成分)混為一談,兩者不同
事實高估恢復/抗發炎效果,忽略安慰劑與儀式感成分(「沒喝也會恢復」)
🩹 社群通報的副作用
  • 輕度腹瀉(「喝了會微拉」)
🏷️ 社群熱議品牌

依論壇被提及頻率,非銷售或品質排序。

  • Swanson 斯旺森(25:1 濃縮 465mg)
  • Nature's Truth
  • Nature's Way
  • Nelum Nutrition(酸櫻桃+生薑)
  • iHerb 通路採購
  • 高濃縮酸櫻桃膠囊(泛指,相對於痛風族群更推的赤晶對策)

⚠️ 列出僅代表「TW 社群討論度高」,不代表本站推薦或背書。本站不販售任何產品、無導購連結。

查看代表討論串 ↗

L10a · 廠商行銷話術 行銷語言
💬 通路如何宣傳

Georgia 喬治亞有機酸櫻桃原汁,高濃度助眠因子,幫助入睡

代表來源 ↗
L10b · TFDA 法定身份 官方認定
🍽️一般食品

食品之標示、宣傳或廣告,不得有不實、誇張或易生誤解之情形;食品不得為醫療效能之標示、宣傳或廣告。

來源 ↗

  • 降尿酸藥物治療(allopurinol/febuxostat)
  • 急性發作抗發炎藥物(NSAIDs/秋水仙素/類固醇)
  • 飲食與生活型態調整
PMID 100% 反查全部經 NCBI Entrez 驗證
🔬 4 篇 L2 文獻 經多層 sub-agent 獨立評估
🇹🇼 含台灣社群分析L10c PTT / Dcard / Mobile01
aggregated_at: 2026-06-01 claim_version: v25 engine_version: v1.0 claim_id: CLM-COND-gout-INT-tart-cherry-001
查看 ClaimReview 結構化資料 (JSON-LD)
{
  "@context": "https://schema.org",
  "@type": "ClaimReview",
  "url": "https://gpt-dict.com/claim/CLM-COND-gout-INT-tart-cherry-001/",
  "datePublished": "2026-06-01",
  "author": {
    "@type": "Organization",
    "name": "gpt-dict.com",
    "url": "https://gpt-dict.com"
  },
  "claimReviewed": "酸櫻桃能改善痛風",
  "inLanguage": "zh-TW",
  "itemReviewed": {
    "@type": "Claim",
    "appearance": []
  },
  "reviewRating": {
    "@type": "Rating",
    "ratingValue": 2,
    "bestRating": 5,
    "worstRating": 1,
    "alternateName": "🟠 C 薄弱證據"
  }
}